DATAMEDS AI INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.92
-5.42%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-52.7%
3 months
-40.7%
6 months
-64.6%
1 year
-95.1%
Year to date
-90.4%
52-week range
$0.85 – $39.32
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$3.1M
P/E
0
P/B
-0.2
P/S
0.4
Revenue
$8.02M
Net income
-$88.28M
Diluted EPS
-46.63
Gross margin
-90.60%
Net margin
-1100.30%
Return on equity
877.60%
Total debt
$32.62M
Cash
$2.54M
Free cash flow
-$14.66M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $1.78M | -$18.36M | 10.20% | -1031.70% | -$3.14M |
| Mar 31, 2026 | $1.56M | -$7.74M | 10.90% | -496.50% | -$3.62M |
| Dec 31, 2025 | $1.67M | -$27.85M | -470.20% | -1667.20% | -$6.55M |
| Sep 30, 2025 | $3.01M | -$34.32M | 7.70% | -1139.00% | -$1.36M |
| Jun 30, 2025 | $7.79M | -$6.67M | 6.50% | -85.60% | -$2.21M |
| Mar 31, 2025 | $10.86M | -$32.43M | 6.40% | -298.50% | -$1.62M |
| Dec 31, 2024 | $12.41M | -$4.33M | 10.10% | -34.90% | -$3.12M |
| Sep 30, 2024 | -$12.29M | -$2.11M | 13.50% | 17.20% | $1.83M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent MEDS news
All market newsNo ticker-linked stories are in the current archive.